/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

B

Bent Ejlertsen

University of Copenhagen(DK)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

423

Papers

22.7K

Citations

65

h-index

198

i10-index

Bent Ejlertsen is an academic researcher from University of Copenhagen. The author has contributed to research in topics: Breast Cancer Treatment Studies & HER2/EGFR in Cancer Research & Cancer Treatment and Pharmacology. The author has an h-index of 65, co-authored 360 publications.

ORCID: 0000-0001-8761-714X

Research Topics

Breast Cancer Treatment Studies HER2/EGFR in Cancer Research Cancer Treatment and Pharmacology Estrogen and related hormone effects Advanced Breast Cancer Therapies

Papers by this author

works

Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

2013 · Annals of Oncology · 3,628 citations

https://doi.org/10.1093/annonc/mdt303

Aron Goldhirsch Eric P. Winer Alan S. Coates Richard D. Gelber

Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015

2015 · Annals of Oncology · 1,820 citations

https://doi.org/10.1093/annonc/mdv221

Alan S. Coates Eric P. Winer Aron Goldhirsch Richard D. Gelber

Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

2016 · The Lancet Oncology · 551 citations

https://doi.org/10.1016/s1470-2045(15)00551-3

Arlene Chan Suzette Delaloge Frankie A. Holmes Beverly Moy

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

2013 · Nature Genetics · 537 citations

https://doi.org/10.1038/ng.2566

Stig E. Bojesen

Association of Type and Location of<i>BRCA1</i>and<i>BRCA2</i>Mutations With Risk of Breast and Ovarian Cancer

2015 · JAMA · 494 citations

https://doi.org/10.1001/jama.2014.5985

Timothy R. Rebbeck Nandita Mitra Fei Wan Olga M. Sinilnikova

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

2017 · Nature Genetics · 464 citations

https://doi.org/10.1038/ng.3785

Research topics

topics

Breast Cancer Treatment Studies

HER2/EGFR in Cancer Research

Cancer Treatment and Pharmacology

Estrogen and related hormone effects

Advanced Breast Cancer Therapies

Chat about Author

Papers

Chat

Click to start Chat